FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

GLOBAL HEALTH Previous Volume 360:106-109 January 8, 2009 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interactive Graphic Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Wang, L.-D. PubMed Citation

Schistosomiasis remains one of the world's most prevalent diseases. Despite more than a century of control efforts and the introduction of highly effective antischistosomal drug therapy in the 1980s, the disease just will not go away. More than 207 million of the world's poorest people are currently infected with schistosomiasis, which is often a decades-long, chronic inflammatory disorder that is associated with disabling anemia and undernutrition as well as poor performance in school and at work.¹

Schistosomiasis, also known as bilharziasis, results from long-lived infection by multicellular intravascular parasites of one of five trematode species — Schistosoma japonicum, S. mansoni, . . . [Full Text of this Article]

Source Information

Dr. King is a professor of international health at the Center for Global Health and Diseases, Case Western Reserve University, Cleveland.

This article has been cited by other articles:

• (2009). Schistosomiasis Elimination: The Snail's Pace Quickens. JWatch Infect. Diseases 2009: 6-6 [Full Text]